Cenuco (AMEX:ICU)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Cenuco Charts. Click Here for more Cenuco Charts.](/p.php?pid=staticchart&s=A%5EICU&p=8&t=15)
Cenuco, Inc. (AMEX:ICU) announced today that it has
advised the American Stock Exchange that Cenuco has made, and
continues to make, excellent progress toward fulfillment of the plan
previously filed with the Amex to bring the company into compliance
with the Amex listing standards. Cenuco advised the Amex that in view
of a significant potential transaction that may be consummated within
the next week, Cenuco, with the concurrence of its independent
auditors, BDO Seidman, LLP, has concluded that it would be advisable
to delay the filing of the pending Quarterly Report on Form 10-Q (the
"Form 10-Q") until the end of next week.
Cenuco announced that it is presently in discussions to finalize
an acquisition agreement that, if consummated, would be Cenuco's first
significant strategic transaction. This potential transaction, if
consummated, would provide the Company with named brands that are
projected to significantly increase annual revenues and could realize
significant additional earnings. Agreements for the financing for this
potential transaction are being negotiated as well. Cenuco stated that
negotiations of the potential acquisition and the financing are
continuing and there can be no assurance that any transaction will be
consummated or if consummated, the terms of any such transaction.
Given the significance of the proposed acquisition and financing,
assuming that the transaction is consummated, management of the
Company believes the disclosures on the Form 10-Q would be more
meaningful with the addition of information finalized at the closing
of this transaction. Cenuco's auditors concur with this assessment.
Cenuco requested and received a one week extension for the filing of
the Form 10-Q.
About Lander
Lander, the health and beauty care division of the Company is a
manufacturer, marketer and distributor of a leading value brand
(LANDER) health and beauty care products. The Company also produces
private label brands for a limited number of top retailers through its
Canadian facility. Lander is a leader in the rapidly growing
marketplace for value health and beauty care (HBC) products - sold in
dollar store and value focused retailers such as Wal-Mart and Kmart.
http://www.lander-hba.com
The Lander brand is recognized as the largest specialty bath brand
as reported in 2004 by Information Resources, Inc. (IRI), a global
provider of market content and business performance management within
consumer goods and retail industries. The company is headquartered in
Lawrenceville, New Jersey. The company operates two manufacturing and
distribution facilities, one in Binghamton, New York and the other in
Toronto, Canada.
About Cenuco
Cenuco, the wireless technology division of the Company develops
wireless and internet based software solutions for transmitting live
streaming video, and other targeted content, directly onto cellular
phones and remote computers. The Company's technology has applications
in a variety of markets. The Company's wireless data technology is
primarily focused on wireless video monitoring solutions that allow
users to view real-time streaming video of security cameras or video
content feeds at their home or place of business from anywhere they
receive a cellular connection, regardless of the cellular carrier,
user's location, or type of cellular phone or wireless device. Visit
http://www.cenuco.com for additional information.
Certain statements contained herein, including statements may
constitute forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, 21E of the Exchange Act of 1934
and/or the Private Securities Litigation Reform Act of 1995. Such
statements include, without limitation, statements regarding a
potential acquisition, projected revenues and earnings, business
plans, future regulatory environment and approval and, the Company's
ability to comply with the rules and policies of independent
regulatory agencies. Although the Company believes the statements
contained herein to be accurate as of the date they were made, it can
give no assurance that such expectations will prove to be correct. The
Company undertakes no obligation to update these forward-looking
statements.